Author

Miriam Helena Fonseca‐Alaniz

Universidade de São PauloORCID 0000-0003-2358-9463Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:simulation· 1 Approach:statistical model· 1

Frequent Co-Authors

Evangelia PetsalakiiD· 1 shared Girolamo GiudiceiD· 1 shared Iguaracy Pinheiro‐de‐SousaiD· 1 shared José Eduardo KriegeriD· 1 shared Sarah Viana-MattioliiD· 1 shared Silvestre Massimo Modestia· 1 shared Yun Hua FangiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Evangelia PetsalakiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systems BiologybioRxivPreprintNov 17, 2022

In silico network-based screening reveals candidates for endothelial dysfunction therapy

Iguaracy Pinheiro‐de‐Sousa, Girolamo Giudice, Miriam Helena Fonseca‐Alaniz…·José Eduardo Krieger

The paper identifies 17 candidate genes for endothelial dysfunction therapy using computational network analysis and in silico perturbation, with one target showing anti-inflammatory and antioxidant effects.

DOI 10.1101/2022.11.17.516953

humanATAC-seq

𝕏 PostBluesky